Overcoming beta-agonist tolerance: high dose salbutamol and ipratropium bromide. Two randomised controlled trials

BACKGROUND: Asthmatics treated with long-acting beta-agonists have a reduced bronchodilator response to moderate doses of inhaled short acting beta-agonists during acute bronchoconstriction. It is not known if the response to higher doses of nebulised beta-agonists or other bronchodilators is impair...

Descripción completa

Detalles Bibliográficos
Autores principales: Haney, Sarah, Hancox, Robert J
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1821019/
https://www.ncbi.nlm.nih.gov/pubmed/17341317
http://dx.doi.org/10.1186/1465-9921-8-19

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1821019/
https://www.ncbi.nlm.nih.gov/pubmed/17341317
http://dx.doi.org/10.1186/1465-9921-8-19

Ejemplares similares